Insider Transactions in Q4 2022 at Aclaris Therapeutics, Inc. (ACRS)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 15
2022
|
Joseph Monahan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.93%
|
$75,000
$15.88 P/Share
|
Nov 14
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
1,371
-0.31%
|
$23,307
$17.08 P/Share
|
Nov 11
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
41,160
-8.63%
|
$699,720
$17.06 P/Share
|
Nov 10
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
11,395
-2.33%
|
$193,715
$17.02 P/Share
|
Nov 08
2022
|
Andrew Kenneth William Powell |
SELL
Bona fide gift
|
Direct |
4,000
-28.87%
|
-
|
Oct 26
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
14,540
-2.89%
|
$247,180
$17.0 P/Share
|
Oct 25
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
12,018
-2.33%
|
$204,306
$17.02 P/Share
|
Oct 24
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
14,616
-2.76%
|
$248,472
$17.01 P/Share
|
Oct 18
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
32,093
-5.71%
|
$513,488
$16.89 P/Share
|
Oct 17
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
19,944
-3.43%
|
$319,104
$16.05 P/Share
|
Oct 17
2022
|
Joseph Monahan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.7%
|
$75,000
$15.98 P/Share
|
Oct 07
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
7,324
-1.24%
|
$117,184
$16.16 P/Share
|
Oct 06
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
37,839
-6.04%
|
$605,424
$16.54 P/Share
|
Oct 04
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
7,700
-1.21%
|
$123,200
$16.01 P/Share
|